ArticleFrontiers in endocrinology2025
Association between hs-CRP/HDL with type 2 diabetes mellitus in middle-aged and elderly people: a cross-sectional study from CHARLS.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Dried blood spot sample extraction for metabolomics and proteomics profiling for clinical trials: a descriptive exploratory study.Scientific reports · 2026Article
- Article
- Sodium pyruvate attenuates oxidative stress, lowers ox-LDL and ox-LDL/LDL-P, and mitigates inflammation in diabetic atherosclerotic rats.Open life sciences · 2026Article
- Cumulative of c-reactive protein-triglyceride glucose index exposure and risk of diabetes in middle-aged and older Chinese adults: findings from a national longitudinal cohort.Diabetology & metabolic syndrome · 2025Article
- S-shaped association between hs-CRP/HDL-C index and overweight/obesity in children and adolescents: a population-based study.European journal of medical research · 2025Article
- Linking high-sensitivity C-reactive protein and dyslipidemia among patients with type 2 diabetes mellitus.Bioinformation · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Research into the relationship between the ratio of high-sensitivity C-reactive protein (hs-CRP) and high-density lipoprotein cholesterol (HDL-C) concerning type 2 diabetes mellitus (T2DM) is still scarce. The hs-CRP/HDL ratio could be an important biomarker for evaluating the risk of developing diabetes. This study primarily aims to investigate the association between hs-CRP/HDL ratios and the incidence of T2DM within a defined population. Methods: This analysis was conducted using data from 9,381 participants aged 45 and older, obtained during the 2011 wave of the China Health and Retirement Longitudinal Study (CHARLS). The study evaluated the association between the hs-CRP/HDL ratio and the risk of developing type 2 diabetes mellitus (T2DM) employing multivariate logistic regression, subgroup analyses, smooth curve fitting, and threshold effect analysis. Results: The overall prevalence of T2DM within the study population was found to be 16.3%, with 46.1% of cases occurring in men and 53.9% in women. Participants diagnosed with T2DM demonstrated a mean hs-CRP/HDL ratio that was 1.2 times higher than that of individuals without diabetes. The adjusted odds ratio (OR) for T2DM associated with hs-CRP/HDL levels was determined to be 0.75 (95% CI: 0.64-0.87). Additionally, a significant interaction was identified between hs-CRP/HDL ratios and variables such as sex and smoking in relation to T2DM risk (P < 0.05). Further subgroup analyses examining factors like age, education, marital status, hukou status, and drinking habits did not reveal any significant interactions (all P values for interaction were >0.05). Conclusions: The results highlight a robust association between the hs-CRP/HDL ratio and the likelihood of developing T2DM, indicating its potential as a predictive biomarker for the condition. Additional research is required to clarify the relationship between hs-CRP/HDL ratios and the incidence of T2DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.